INMB
INmune Bio Inc
2.00$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | |
| 100.0% | 100.0% | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | |
| 13,918.6% | 21,453.6% | 62,092.9% | – | – | – | 15,278.0% | – | – | – | – | – | – | |
| 6,014.0% | 8,571.4% | 16,700.0% | – | – | – | 4,632.0% | – | – | – | – | – | – | |
| 19,932.6% | 30,025.0% | 78,792.9% | – | – | – | 19,910.0% | – | – | – | – | – | – | |
| -19,832.6% | -29,925.0% | -78,692.9% | – | – | – | -19,810.0% | – | – | – | – | – | – | |
| – | 403.6% | – | – | – | – | – | – | – | – | – | – | – | |
| -19,914.0% | -30,028.6% | -78,750.0% | – | – | – | -19,478.0% | – | – | – | – | – | – | |
| -19,832.6% | 52,950.0% | -78,692.9% | – | – | – | – | – | – | – | – | – | – | |
| -19,914.0% | -30,028.6% | -78,750.0% | – | – | – | -19,478.0% | – | – | – | – | – | – | |
| -81.4% | -29,925.0% | -78,507.1% | – | – | – | -19,478.0% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.